What are the Potential Side Effects of Drinking Jeera and Methi Water?
Do you know that excess Jeera (Cumin) or methi (Fenugreek) water can pose side effects? It is hard to believe that these culinary herbs can also have ...
Lupin Receives Approval for Sulfamethoxazole and Trimethoprim Oral Suspension USP
Wednesday January 6, 2021 at 12:36 pmMumbai, Baltimore, January 6, 2021: Lupin Limited (Lupin), global pharmaceutical company, announced today that it has received approval for its Sulfamethoxazole and Trimethoprim Oral Suspension USP, 200 mg/40 mg per 5 mL, from the United States Food and Drug Administration, to market a generic equivalent of Bactrim Oral Suspension, 200 mg/40 mg per 5 mL, of Sun Pharmaceutical Industries, Inc.
Sulfamethoxazole and Trimethoprim Oral Suspension USP, 200 mg/40 mg per 5 mL, is indicated for the treatment and prevention of a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections), and certain type of pneumonia (pneumocystis-type).
Sulfamethoxazole and Trimethoprim Oral Suspension USP (RLD: Bactrim) had estimated annual sales of approximately USD 19 million in the U.S. (IQVIA MAT September 2020).
